Abstract:Coronavirus disease 2019 (COVID-19) is caused by the novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and first emerged in December 2019 in Wuhan, Hubei province, China. Since then, the virus has rapidly spread to many countries. While the outbreak in China appears to be in decline, the disease has spread across the world, with a daily increase in the number of confirmed cases and infection-related deaths. Here, we highlight (i) the lessons that have been learnt so far and how they will benefit reducing the impact of COVID-19 disease and (ii) an update on the status of drug treatment and vaccine development to prevent COVID-19 and potential future related pandemics. Although the mortality rate is clearly higher than for influenza, the rate does seem to vary from country to country, possibly reflecting differences in how rapidly local health authorities respond to isolate and effectively care for the affected population. Drugs are urgently needed for both prophylaxis and the treatment of severely ill patients; however, no proven effective therapies for SARS-CoV-2 currently exist. A number of drugs that have been approved for other diseases are being tested for the treatment of COVID-19 patients, but there is an absence of data from appropriately designed clinical trials showing that these drugs, either alone or in combination, will prove effective. There is also a global urgency to develop a vaccine against COVID-19, but development and appropriate testing will take at least a year before such a vaccine will be globally available. This review summarizes the lessons learnt so far from the COVID-19 pandemic, examines the evidence regarding the drugs that are being tested for the treatment of COVID19, and describes the progress made in efforts to develop an effective vaccine.

Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment

Update on treatment and preventive interventions against COVID-19: an overview of potential pharmacological agents and vaccines

Progress in SARS-CoV-2, Diagnostic and Clinical Treatment of COVID-19

Overview of Therapeutic Drug Research for COVID-19 in China

An overview of the safety, clinical application and antiviral research of the COVID-19 therapeutics

Recent progress of antiviral therapy for coronavirus disease 2019

An Update on Current Therapeutic Drugs Treating COVID-19

Potential therapeutic options for COVID-19: an update on current evidence

Drug Clinical Trial of COVID-19 in China: A Brief Analysis

Recent Insights for the Emerging COVID-19: Drug Discovery, Therapeutic Options and Vaccine Development

Current treatment strategies for COVID‐19 (Review)

Update: Drug Treatment Options for Coronavirus Disease 2019 (COVID-19).

Drug treatment of coronavirus disease 2019 (COVID-19) in China.

Reviews on Biological Activity, Clinical Trial and Synthesis Progress of Small Molecules for the Treatment of COVID-19

Current status of potential therapeutic candidates for the COVID-19 crisis

Research progress in antiviral therapy for novel coronavirus pneumonia

Current and future therapeutical approaches for COVID-19

Modalities and Mechanisms of Treatment for Coronavirus Disease 2019

Medication Therapy Strategies for the Coronavirus Disease 2019 (COVID-19): Recent Progress and Challenges

COVID-19: Learning from Lessons to Guide Treatment and Prevention Interventions.